Systematic review and meta-analysis of 18 prospective studies (1,670 patients) in early breast cancer: ctDNA positivity was associated with shorter disease-free survival (pooled HR 6.92); the trend for worse overall survival was not significant.
Meta-analysisn = 1,670 patients
Sisca et al. Prognostic significance of circulating tumor DNA in early breast cancer: a systematic review and meta-analysis